Literature DB >> 23410678

iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.

Shishuai Su1, Hai Wang, Xiaoguang Liu, Yan Wu, Guangjun Nie.   

Abstract

In this investigation, we have designed and synthesized a multifunctional nanogel for anti-tumor drug delivery. Thermo- and pH-responsive poly (N-isopropyl acrylamide-co-acrylic acid) nanogels (NGs) were synthesized by free radical precipitation polymerization. Positive charged chemotherapeutic drug doxorubicin (DOX) was introduced into the negatively charged swollen NGs by electrostatic adsorption at pH 7.4. Fluorescent bovine serum albumin (BSA) encapsulated gold nanoclusters (AuNCs) were conjugated onto the surface of NGs, followed by functionalization of tumor targeting peptide iRGD onto the BSA for tumor targeting. Interestingly, the DOX-encapsulated iRGD-decorated NGs maintain both thermo- and pH-responsive properties, which are favorable for achieving a controlled drug release in tumor tissues. Stable red fluorescent emission, derived from AuNCs, was used to detect and track the NGs in vitro. As expected, the iRGD motif mediated specific targeting to tumor and endothelial cells and enhanced cellular uptake of the NGs, as demonstrated by flow cytometry and confocal microscopy assays. In vitro cytotoxicity studies proved that the presence of iRGD enhanced the cytotoxic efficiency of DOX to the targeted cells. All together, our current study indicates that the NGs drug-carriers can deliver chemotherapeutic drug specifically to the tumor and endothelial cells with enhanced anti-tumor efficacy and controlled drug release.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23410678     DOI: 10.1016/j.biomaterials.2013.01.083

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  17 in total

1.  Bovine serum albumin nanoparticles with fluorogenic near-IR-emitting squaraine dyes.

Authors:  Yuanwei Zhang; Xiling Yue; Bosung Kim; Sheng Yao; Mykhailo V Bondar; Kevin D Belfield
Journal:  ACS Appl Mater Interfaces       Date:  2013-08-30       Impact factor: 9.229

2.  Targeted drug delivery using iRGD peptide for solid cancer treatment.

Authors:  Xiangsheng Liu; Jinhong Jiang; Ying Ji; Jianqin Lu; Ryan Chan; Huan Meng
Journal:  Mol Syst Des Eng       Date:  2017-08-16

3.  Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatform.

Authors:  Hai Wang; Pranay Agarwal; Yutong Liang; Jiangsheng Xu; Gang Zhao; Katherine H R Tkaczuk; Xiongbin Lu; Xiaoming He
Journal:  Biomaterials       Date:  2018-07-17       Impact factor: 12.479

Review 4.  Stimulus-responsive polymeric nanogels as smart drug delivery systems.

Authors:  Sakineh Hajebi; Navid Rabiee; Mojtaba Bagherzadeh; Sepideh Ahmadi; Mohammad Rabiee; Hossein Roghani-Mamaqani; Mohammadreza Tahriri; Lobat Tayebi; Michael R Hamblin
Journal:  Acta Biomater       Date:  2019-05-13       Impact factor: 8.947

Review 5.  Monodisperse Gold Nanoparticles: A Review on Synthesis and Their Application in Modern Medicine.

Authors:  Mohammed Ali Dheyab; Azlan Abdul Aziz; Pegah Moradi Khaniabadi; Mahmood S Jameel; Nazila Oladzadabbasabadi; Selwan Abduljabbar Mohammed; Raja Saleh Abdullah; Baharak Mehrdel
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

6.  Activatable iRGD-based peptide monolith: Targeting, internalization, and fluorescence activation for precise tumor imaging.

Authors:  Hong-Jun Cho; Sung-Jin Lee; Sung-Jun Park; Chang H Paik; Sang-Myung Lee; Sehoon Kim; Yoon-Sik Lee
Journal:  J Control Release       Date:  2016-06-24       Impact factor: 9.776

7.  Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.

Authors:  Hai Wang; Pranay Agarwal; Shuting Zhao; Ronald X Xu; Jianhua Yu; Xiongbin Lu; Xiaoming He
Journal:  Biomaterials       Date:  2015-08-29       Impact factor: 12.479

8.  A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.

Authors:  Qing Zhang; Yang Zhang; Ke Li; Haiyu Wang; Huizhong Li; Junnian Zheng
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

9.  The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.

Authors:  Ke-Fu Yu; Wei-Qiang Zhang; Li-Min Luo; Ping Song; Dan Li; Ruo Du; Wei Ren; Dan Huang; Wan-Liang Lu; Xuan Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2013-07-15

Review 10.  Nanogels as a Versatile Drug Delivery System for Brain Cancer.

Authors:  Brielle Stawicki; Tyler Schacher; Hyunah Cho
Journal:  Gels       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.